Evidence map›Paper›PMID 41112299›Full record

ArticleFrontiers in immunology2025

SPP1+macrophages promote fibroblast-to-myofibroblast transformation during hypoxia in deep fascia of acute compartment syndrome.

Liujie Zheng, Guoqiang Li, Jingcheng Cao, Zihang Zhao, Haofei Wang, Qi Dong, Zhiyong Hou

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Liujie Zheng *Department of Orthopedic Surgery, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.
Guoqiang Li *Department of Orthopedic Surgery, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.
Jingcheng Cao *Department of Orthopedic Surgery, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.
Zihang ZhaoDepartment of Orthopedic Surgery, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.
Haofei WangDepartment of Orthopedic Surgery, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.
Qi DongDepartment of Orthopedic Surgery, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.
Zhiyong HouDepartment of Orthopedic Surgery, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute compartment syndrome (ACS) is a life-threatening condition characterized by elevated intracompartmental pressure leading to ischemia, hypoxia and tissue necrosis. We have observed an increase in SPP1+macrophages and fibroblast activation in the deep fascia of ACS patients. However, the mechanisms underlying the pathological changes in terms of macrophage activation and fibroblast responses remain poorly understood. Objectives: This study aims to investigate whether hypoxia induces SPP1 Methods: Macrophages were cultured under normoxic and hypoxic conditions, with or without SPP1 siRNA transfection. The concentration of SPP1 in the macrophage-conditioned media was determined using an ELISA assay. The culture supernatant from each condition was then applied to fibroblasts, which were subsequently analyzed for mRNA and protein expression of fibroblast activation markers by qRT-PCR and WB, respectively. Results: Hypoxia significantly upregulated SPP1 expression in macrophages, as well as in the macrophage-conditioned media. Moreover, hypoxia-stimulated macrophages promoted fibroblast expression of ACTA2, CTGF, collagen I, collagen III, and FN1 at both mRNA and protein levels. This effect was reversed by SPP1 siRNA transfection. Conclusions: Hypoxia induces SPP1+macrophages, which in turn activate fibroblasts, driving myofibroblast transformation in ACS. Targeting this pathway may provide a potential therapeutic strategy for mitigating fibrosis and improving outcomes in ACS.

Indexed as

FasciaFibroblastsHypoxiaMacrophagesMyofibroblastsCell HypoxiaCells, CulturedCulture Media, ConditionedFemaleHumansMacrophage ActivationMaleMiddle AgedOsteopontinCulture Media, ConditionedOsteopontinSPP1 protein, humanacute compartment syndromefasciafibroblasthypoxiamacrophage

Identifiers

PMID41112299
PMCPMC12528148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.